Biotech ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure November 9, 2026
Biotech argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis November 8, 2026
Technology Diginex Announces Extension of Long Stop Date for Proposed Acquisition of Resulticks and Convenes Extraordinary General Meeting November 8, 2026
Technology Parker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time) November 7, 2026
Technology Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividend November 7, 2026
Financial SPACCircle Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares, Warrants and Rights, Commencing November 10, 2026 November 7, 2026
Biotech Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026 November 7, 2026
Health LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026 November 7, 2026